@untamed inferno @Sanchit Jain You cannot go in this one on the basis of GMP and other related factors. Chances of negative listing can't be denied. Sector is under pressure and prone to getting over crowded. They have further came in the issue with reduced size. Established peers have higher ROE, so that's why Fedfina looks costly at current price bands.
AUM is progressing, NPA isn't the highest in the category but RoA is low, the reason why despite high leverage ROE is low. They have a clear opportunity to cross-sell it along with Fedbank. Plus region wise benefits can be achieved. Anchor book despite all of the above is actually good, so that brings some hope.
All in all, clear long term bet only if appetite to hold and see negatives is present. Totally avoid if short term oriented view and if a bet for long term is taken, a more thoughtful one would be with someone with the likes of Fedfina rather than say, someone like Pidilite entering lending business. Rest the call is yours.